Key statistics
On Friday, Oruka Therapeutics Inc (HQ1:STU) closed at 26.70, 59.50% above the 52 week low of 16.74 set on Feb 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.95 |
---|---|
High | 26.70 |
Low | 25.95 |
Bid | 25.80 |
Offer | 28.35 |
Previous close | 25.85 |
Average volume | 0.00 |
---|---|
Shares outstanding | 35.00m |
Free float | 34.92m |
P/E (TTM) | -- |
Market cap | 1.04bn USD |
EPS (TTM) | -5.97 USD |
Data delayed at least 15 minutes, as of Oct 18 2024.
More ▼
Announcements
- Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
- Oruka Therapeutics Announces $200 Million Private Placement
- Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19
- Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million